Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Learn which credit card has no annual fee and offers the best benefits for your spending habits. Make a smart choice!
28,655 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
When a trusted bookkeeper holds the keys to a company’s wire transfers, financial risk rises. This guide explains how...
OpenAI leads the 2026 IPO chatter, with Stripe and Consensys jockeying for position as investors weigh odds, valuatio...
Berkshire Hathaway stands out as a core, set-it-and-forget-it holding as markets wobble in 2026. Its fortress balance...
As DNOW readies its 2025 earnings narrative, investors should focus on backlog, free cash flow, and guidance. This gu...
A sharp February pullback put Intel back in focus. This guide breaks down the drivers, the long-term thesis, and how ...
Anthropic is widening who can tap into Claude Mythos, just as IPO chatter heats up in the AI arena. This move could r...
A massive AI-driven data center build-out is changing how investors think about tech stocks. This piece explains the ...
A rising AI-driven marketing platform secures a NASDAQ ticker and raises over $50 million, signaling a new wave of in...
Oklo stock fell 24% over the past month as retail traders on Reddit rally around a bold $250 target by July 4, bracin...
Volatility can create buying opportunities. Here's one hypergrowth tech stock 2026 pick that blends AI momentum, scal...
Nvidia investors should watch TSMC's latest results closely. When the world’s largest chipmaker signals stronger dema...